Medication info
BESDUO Tablet 20/800 mg

BESDUO Tablet 20/800 mg

Prescription medicationTabletOral
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.26mg / 1 tabletSodium Bicarbonate›800mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Light pink oblong film-coated tablet
Packaging
28 tablets (7 tablets/PTP × 4)
Approval status
Active

MFDS item code 202104747 · Approved 2021.06.18 · Insurance code 644103410

Summary

Main use
Treatment and prevention of recurrence of gastroesophageal reflux disease (reflux esophagitis, etc.)
Who takes it
Adults
Adult dose
Take this medicine on an empty stomach at least 1 hour before a meal. Swallow this medicine whole with at least half a glass of water. Do not take it with any beverage other than water. Do not chew or crush this medicine. The 20/800mg and 40/800mg strengths of this medicine contain 20 and 40mg of esomeprazole, respectively. However, be aware that the amount of sodium bicarbonate in 2 tablets of 20/800mg is not the same as that in 1 tablet of 40/800mg. 1. Adults Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Take 40/800mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking the medicine for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20/800mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis · 20/800mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by taking 20/800mg once daily. · In adults, 20/800mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2. Hepatic impairment: No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20/800 mg of this medicine.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of recurrence of gastroesophageal reflux disease (reflux esophagitis, etc.)

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • symptoms of gastroesophageal reflux disease
View approved original text

This medication is used to treat gastroesophageal reflux disease, particularly erosive reflux esophagitis. It also helps to prevent the recurrence of the disease in patients with esophagitis through prolonged maintenance therapy. It is effective in alleviating symptoms of gastroesophageal reflux disease in patients without esophagitis, helping improve symptoms overall. It is used to treat reflux-related issues in the stomach and esophagus and to prevent recurrence.

How to take

Adult dose

Take this medicine on an empty stomach at least 1 hour before a meal. Swallow this medicine whole with at least half a glass of water. Do not take it with any beverage other than water. Do not chew or crush this medicine. The 20/800mg and 40/800mg strengths of this medicine contain 20 and 40mg of esomeprazole, respectively. However, be aware that the amount of sodium bicarbonate in 2 tablets of 20/800mg is not the same as that in 1 tablet of 40/800mg. 1. Adults Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Take 40/800mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking the medicine for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20/800mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis · 20/800mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by taking 20/800mg once daily. · In adults, 20/800mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2. Hepatic impairment: No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20/800 mg of this medicine.

Precautions

This medication should not be administered to patients with an allergy to this medication or its components or who have shown hypersensitivity. Patients taking certain antiviral drugs, those who are breastfeeding, or those with a history of heart disease should not use this medication. Patients with impaired liver or kidney function, the elderly, or those with heart and lung function problems should use this medication with caution. Adverse effects can arise from this medication, so if symptoms such as headaches, dizziness, gastrointestinal symptoms, or skin rashes occur, medical advice should be sought immediately. Regular testing to monitor liver function and electrolyte levels is essential for long-term use. Since this medication lowers gastric acidity due to its proton pump inhibitor component, the risk of gastrointestinal infections may increase; therefore, the doctor should be informed if diarrhea persists. This medication has many drug interactions, particularly when taken with antiviral medications, anticoagulants, or anticonvulsants; thus, expert guidance should be followed. If pregnant or breastfeeding, consultation with a physician is necessary before use since its safety has not been adequately established. In the case of overdose, there is no specific antidote, so appropriate treatment should be given based on symptoms, and it should be kept out of reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbances, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lhermitte's syndrome, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, renal tubular interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid gland enlargement, irritable bowel syndrome, worsening of constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening of depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, worsening of migraine, sleep disorders, tremor, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, worsening of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbances, loss of taste, taste alteration, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis, alkalosis, edema, gastric distension, belching, rebound secretion of gastric acid

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is safest when kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Light pink oblong film-coated tablet

Package unit

28 tablets (7 tablets/PTP × 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.